Accessories
Feb 2026Top Accessories brands in West Virginia: Puffco, O.Pen Vape, Rokin Vapes.
Feb 2026
West Virginia's cannabis market contracted 35.5% year-over-year as of February 2026, one of the steepest declines among small-tier U.S. markets, even as its dispensary count grew 6.5% to 66 locations. The divergence between expanding retail access and shrinking sales suggests the medical-only program is losing patients rather than gaining them, with average prices also falling 8.8% over the past year. Over a two-year horizon the market is down 12.1%, confirming this is not a single-quarter anomaly but a sustained contraction in a state where competition from neighboring recreational markets in Virginia and Ohio may be siphoning demand. ALTSOL leads among brands operating in the state. West Virginia legalized medicinal marijuana in 2017 and licensed dispensary sales began in 2021. No recreational program has been authorized.
Benchmarking
Among Appalachian medical markets, West Virginia stands out for the sharpness of its decline: sales fell 35.5% year-over-year and are down 12.1% over two years, even while store count edged up to 66 dispensaries. Neighboring Ohio launched adult-use sales in 2024, and Virginia's expanding program likely pulls patients across the border, compounding pressure on a small-tier market that has yet to find a growth catalyst.
24-Month Trend

| State | Sales | YoY |
|---|---|---|
| Puerto Rico | $10-15M | 19.0% |
| Rhode Island | $5-10M | 35.7% |
| West Virginia | $5-10M | 35.5% |
| District of Columbia | $5-10M | 34.8% |
| South Dakota | $5-10M | 0.9% |
Category View
Concentrates suffered the most dramatic pullback in West Virginia, plunging 57.4% year-over-year while still holding 7.5% of the market. Vapes fell 39.4% and flower dropped 30.3%, though flower remains dominant at 61.2% of total sales. The only growth came from the smallest segments: oral products climbed 34.6% and accessories rose 24.1%, together accounting for just 2.3% of the market. ALTSOL continues to lead among brands, operating within a category landscape where the core segments are all contracting at double-digit rates.
| Category | Sales | Avg Price | YoY |
|---|---|---|---|
| #1Flower | $2.5-5M | $43.89 | 30.3% |
| #2Vapes | $1-2.5M | $38.84 | 39.4% |
| #3Concentrates | $250-500K | $41.64 | 57.4% |
| #4Oral | <$250K | $38.8 | 34.6% |
| #5Accessories | <$250K | $28.24 | 24.1% |
| #6Topicals | <$250K | $30.25 | 56.3% |
Top Brands
Category leaders show which brands are currently strongest by segment in West Virginia, with 1-month rank movement when available.
Top Accessories brands in West Virginia: Puffco, O.Pen Vape, Rokin Vapes.
Top Concentrates brands in West Virginia: Country Grown Cannabis, Muse, The Essence.
Top Flower brands in West Virginia: Altsol, Strane, Hillfire.
Top Oral brands in West Virginia: Rx Pharma, Momenta, Altsol.
Top Topicals brands in West Virginia: Avexia, Rx Pharma, Momenta.
Top Vapes brands in West Virginia: Hillfire, Country Grown Cannabis, The Essence.
Product Leaders
Top ranked products by category for West Virginia, based on the latest state-category product snapshot.
| Product | Brand | Feb 2026 | Jan 2026 | Dec 2025 |
|---|---|---|---|---|
| Country Grown Cannabis | #1 | #1 | N/A | |
| Honey | #2 | #11 | #14 | |
| Country Grown Cannabis | #3 | #6 | #1 | |
| Country Grown Cannabis | #4 | #12 | #19 | |
| Honey | #5 | #19 | #13 |
| Product | Brand | Feb 2026 | Jan 2026 | Dec 2025 |
|---|---|---|---|---|
| Cookies | #1 | N/A | #11 | |
| Avexia | #2 | #7 | #1 | |
| Avexia | #3 | #4 | #29 | |
| The Essence | #4 | #8 | #25 | |
| Trulieve | #5 | #1 | #14 |
| Product | Brand | Feb 2026 | Jan 2026 | Dec 2025 |
|---|---|---|---|---|
| Avexia | #1 | #1 | #3 | |
| Avexia | #2 | #2 | #1 | |
| Avexia | #3 | #3 | #2 | |
| Hillfire | #4 | #5 | #6 | |
| Avexia | #5 | #7 | #5 |
| Product | Brand | Feb 2026 | Jan 2026 | Dec 2025 |
|---|---|---|---|---|
| Puffco | #1 | #1 | #1 | |
| O.Pen Vape | #2 | #7 | #8 | |
| Puffco | #3 | #2 | #2 | |
| Heir | #4 | #6 | #12 | |
| Puffco | #5 | #4 | #4 |
| Product | Brand | Feb 2026 | Jan 2026 | Dec 2025 |
|---|---|---|---|---|
| Avexia | #1 | #2 | #1 | |
| Avexia | #2 | #3 | #2 | |
| Momenta | #3 | #4 | #3 | |
| Avexia | #4 | #1 | #4 | |
| Rx Pharma | #5 | #5 | #8 |
Get full buyer and category intelligence for this market.